Orchestra BioMed (OBIO)

Orchestra BioMed (OBIO) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• OBIO last traded at $5.58, -0.71% on the day.
• Orchestra BioMed: market cap $342.91M, P/E -5.7, revenue $31.98M over the last four quarters.
• Over the past year OBIO returned 42.35%; year to date 34.46%.

Updated 2026-11-07 12:00 UTC